Prostaglandin E1 inhibits DNA synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor.

[1]  G. Guroff.  Growth and Maturation Factors , 1984 .

[2]  R. Ralph,et al.  Cyclic AMP, calcium and control of cell growth , 1983, FEBS letters.

[3]  M. Waterfield,et al.  Platelet-derived growth factor elicits cyclic AMP accumulation in swiss 3T3 cells: Role of prostaglandin production , 1983, Cell.

[4]  C. Heldin,et al.  Demonstration of stimulatory effects of platelet-derived growth factor on cultivated rat arterial smooth muscle cells. Differences between cells from young and adult animals. , 1983, Experimental cell research.

[5]  J. Thyberg,et al.  Effects of colchicine on DNA synthesis, endocytosis and fine structure of cultivated arterial smooth muscle cells. , 1983, Experimental cell research.

[6]  B. D. Boss,et al.  Prostaglandins E1 and E2 interact with prostaglandin F2alpha to regulate initiation of DNA replication and cell division in swiss 3T3 cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[7]  E. Rozengurt.  Adenosine receptor activation in quiescent Swiss 3T3 cells. Enhancement of cAMP levels, DNA synthesis and cell division. , 1982, Experimental cell research.

[8]  C. Heldin,et al.  Platelet-derived growth factor. Isolation by a large-scale procedure and analysis of subunit composition. , 1981, The Biochemical journal.

[9]  M. Moskowitz,et al.  Platelet-dependent stimulation of prostacyclin synthesis by platelet-derived growth factor , 1980, Nature.

[10]  H. Claésson.  Prostaglandin I2 synthesis and elevation of cyclic AMP levels in 3T3 fibroblasts. , 1980, Biochimica et biophysica acta.

[11]  M. Caton,et al.  Prostaglandins and thromboxanes. , 1979, Progress in medicinal chemistry.

[12]  J. Vane,et al.  Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species. , 1978, Prostaglandins.

[13]  G. Milo,et al.  Fatty acids and their prostaglandin derivatives: inhibitors of proliferation in aortic smooth muscle cells. , 1977, Science.

[14]  L. Taylor,et al.  Effects of prostaglandin on substrate uptake and cell division in human diploid fibroblasts. , 1977, The Biochemical journal.

[15]  R. Ross,et al.  The pathogenesis of atherosclerosis (second of two parts). , 1976, The New England journal of medicine.

[16]  R. Ross,et al.  The pathogenesis of atherosclerosis (first of two parts). , 1976, The New England journal of medicine.

[17]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[18]  W. Pledger,et al.  Elevated intracellular concentrations of cyclic AMP inhibited serum‐stimulated, density‐arrested BALB/c‐3T3 cells in mid G1 , 1982, Journal of cellular biochemistry.

[19]  J. Mcgiff.  Prostaglandins, prostacyclin, and thromboxanes. , 1981, Annual review of pharmacology and toxicology.

[20]  W. Shier.  Serum stimulation of phospholipase A2 and prostaglandin release in 3T3 cells is associated with platelet-derived growth-promoting activity. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[21]  T. Nikkari,et al.  Prostaglandins enhance the synthesis of glycosaminoglycans and inhibit the growth of rabbit aortic smooth muscle cells in culture. , 1980, Artery.

[22]  G. S. Johnson,et al.  Role of cyclic nucleotides in growth control. , 1975, Annual review of biochemistry.

[23]  Ekins Rp,et al.  Saturation assay for cyclic AMP using endogenous binding protein. , 1972 .